logo

For the Inventor, By the Inventor

Schwalbach, Germany

Josef Urbanietz

This inventor holds 10 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1976-1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josef Urbanietz. Retrieved from https://idiyas.com/inventor/josef-urbanietz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 39(Granted Patents)


Location History:

  • Schwalbach, Taunus, DE (1976 - 1978)
  • Schawalbach, DE (1980)
  • Schwalbach, DE (1979 - 1985)

Company Filing History:

goldMedal10 out of 6,705 
 
Hoechst Aktiengesellschaft
 patents

Years Active: 1976-1985

Loading Chart...
10 patents (USPTO):Explore Patents
1. 4504490 - Substituted benzenesulfonic esters and their use as medicaments for (1985-03-12),
2. 4254143 - Monocarboxylates of phenylguanidinesulfonic acid esters, a process for (1981-03-03),
3. 4216161 - 3,4-Diaminophenyl sulfonic acid esters (1980-08-05),
4. 4176192 - Substituted phenylguanidines and process for their manufacture (1979-11-27),
5. 4069325 - 3-Carbalkoxyamino-1H-2,1,4-benzothiadiazine derivatives (1978-01-17),
6. 4010272 - Anthelmintically active basically substituted (1977-03-01),
7. 3996369 - Anthelmintically active 2-carbalkoxyamino benzimidazolyl-5(6)-sulfonic (1976-12-07),
8. 3996368 - Anthelmintically active 2-carbalkoxyamino-5(6)-phenyl sulfonyloxy (1976-12-07),
9. 3984561 - Anthelmintically active 2-carbalkoxy-amino-benzimidazole-5(6)-phenyl (1976-10-05),
10. 3954791 - Anthelmintically active 2-carbalkoxy-amino-benzimidazole-5(6)-phenyl (1976-05-04),

Title: The Innovative Contributions of Josef Urbanietz

Introduction

Josef Urbanietz is a notable inventor based in Schwalbach, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that combat helminth infections in humans and animals. With a total of 10 patents to his name, Urbanietz's work has had a meaningful impact on medical treatments.

Latest Patents

Among his latest patents, Urbanietz has developed substituted benzenesulfonic esters that serve as effective medicaments. These new compounds are specifically designed to target helminths, providing a solution for worm infections. Additionally, he has patented monocarboxylates of phenylguanidinesulfonic acid esters, which are also effective against helminths and liver flukes when administered either orally or parenterally.

Career Highlights

Urbanietz has spent a significant portion of his career at Hoechst Aktiengesellschaft, where he has been able to apply his innovative ideas in a collaborative environment. His work has not only advanced the field of medicinal chemistry but has also contributed to the development of new therapeutic agents.

Collaborations

Throughout his career, Urbanietz has collaborated with esteemed colleagues such as Heinz Loewe and Reinhard Kirsch. These partnerships have fostered an environment of innovation and have led to the successful development of various medicinal compounds.

Conclusion

Josef Urbanietz's contributions to medicinal chemistry through his patents and collaborations highlight his role as a significant inventor in the field. His work continues to influence the development of effective treatments for helminth infections, showcasing the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…